Efficacy and prediction analysis of pegylated interferon alpha-2b in treatment-naive HBeAg negative chronic hepatitis B patients with normal ALT: a multicenter real-world study (Ice-breakting Project in China)-Interim analysis

被引：0

作者：

Zhang, Chong ^{[1
]}

Zeng, Da-Wu ^{[2
]}

Cai, Da-Chuan ^{[3
]}

Xue, Xiu-Lan ^{[4
]}

Zhang, Ling-Yi ^{[5
]}

Song, Bao-Jun ^{[6
]}

Gao, Yu-Feng ^{[7
]}

Huang, Yan ^{[8
]}

Shang, Jia ^{[9
]}

Wu, Xiao-Feng ^{[10
]}

Zhang, Ying ^{[11
]}

Jin, Hua ^{[12
]}

Chen, Hui ^{[13
]}

Tang, Hong ^{[14
]}

Lu, Xiaobo ^{[15
]}

Guan, Yujuan ^{[16
]}

Min, Feng ^{[17
]}

Xu, Liang ^{[18
]}

Li, Gang ^{[19
]}

Wang, Zhen-Guang ^{[20
]}

Dou, Xiaoguang ^{[1
]}

机构：

[1] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China

[2] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China

[3] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China

[4] Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China

[5] Lanzhou Univ, Hosp 2, Lanzhou, Peoples R China

[6] Sixth Peoples Hosp Fushun, Fushun, Peoples R China

[7] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China

[8] Cent South Univ, Xiangya Hosp, Changsha, Peoples R China

[9] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China

[10] Sixth Peoples Hosp Shenyang, Shenyang, Peoples R China

[11] Dalian Publ Hlth Med Ctr, Dalian, Peoples R China

[12] Sixth Peoples Hosp Benxi, Benxi, Peoples R China

[13] Hepatobiliary Hosp Jilin, Changchun, Jilin, Peoples R China

[14] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China

[15] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China

[16] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Peoples R China

[17] Army Seventy Three Army Hosp, Beijing, Peoples R China

[18] Tianjin Second Peoples Hosp, Tianjin, Peoples R China

[19] Liaohe Oilfield Gen Hosp, Panjin, Peoples R China

[20] Anshan City Hosp Infect Dis, Anshan, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-193

引用

页码：S1165 / S1166

页数：2

共 50 条

[31] Comparative analysis of Peg-Interferon alpha-2b and Lamivudine in the treatment of chronic hepatitis B patients: Preliminary results
Koliouskas, D
Sidiropoulos, I
Masmanidou, M
Dokas, S
Ziakas, A
JOURNAL OF HEPATOLOGY, 2002, 36 : 237 - 238
[32] Effectiveness and Safety of Tenofovir Alafenamide in Treatment-Naive and Treatment-Experienced Patients with Chronic Hepatitis B: Results of a Real-World Study from China
Li, Lan-Qing
Wang, Fa-Da
Zhou, Jing
Wang, Meng-Lan
Tao, Yachao
Chen, En-Qiang
HEPATITIS MONTHLY, 2023, 23 (01)
[33] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN TREATMENT NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: RESULTS OF A REAL-WORLD STUDY FROM CHINA
Chen, Enqiang
Li, Lanqing
Zhou, Jing
Wang, Fada
HEPATOLOGY, 2022, 76 : S320 - S321
[34] Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study
GianPiero Benetti
Mauro Borzio
Giuliano Ramella
Giorgio Bellati
Silvia Fargion
Alberto Colombo
Guido Croce
Carlo Iamoletti
Federico Balzola
Mario Rizzetto
Internal and Emergency Medicine, 2006, 1 : 113 - 118
[35] Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study
Benetti, GianPiero
Borzio, Mauro
Ramella, Giuliano
Bellati, Giorgio
Fargion, Silvia
Colombo, Alberto
Croce, Guido
Iamoletti, Carlo
Balzola, Federico
Rizzetto, Mario
INTERNAL AND EMERGENCY MEDICINE, 2006, 1 (02) : 113 - 118
[36] REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS
Bektas, Erdem
Yilmaz, Aysenur
Kikili, Cevat Ilteris
Nuriyev, Kenan
Istemihan, Zulal
Senkal, Ibrahim Volkan
Imanov, Ziya
Cavus, Bilger
Ormeci, Asli Cifcibasi
Akyuz, Filiz
Demir, Kadir
Besisik, Fatih
Kaymakoglu, Sabahattin
HEPATOLOGY, 2022, 76 : S299 - S299
[37] ON-TREATMENT PREDICTION OF SUSTAINED RESPONSE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGYLATED INTERFERON ALFA-2A
Rijckborst, Vincent
Hansen, Bettina E.
Tabak, Fehmi
Raptopoulou-Gigi, Maria
Ormeci, Necati
Simon, Krzysztof
Akarca, Ulus S.
Flisiak, Robert
Vafiadis-Zouboulis, Irini
Tripi, Silvio
Verhey, Elke
ter Borg, Martijn
van Vuuren, Anneke J.
Janssen, Harry L.
HEPATOLOGY, 2009, 50 (04) : 539A - 540A
[38] Evaluation of long-term efficacy of interferon alpha-2b and ribavirin in combination in naive patients with chronic hepatitis C:: An Italian multicenter experience
Barbaro, G
Di Lorenzo, G
Belloni, G
Ferrari, L
Paiano, A
Del Poggio, J
Bacca, D
Fruttaido, L
Mongiò, F
Francavilla, R
Scotto, G
Grisorio, B
Calleri, G
Annese, M
Barelli, A
Rocchetto, P
Rizzo, G
Gualandi, G
Poltronieri, I
Pellicelli, A
Barbarini, G
JOURNAL OF HEPATOLOGY, 2000, 32 : 100 - 100
[39] Evaluation of long-term efficacy of interferon alpha-2b and ribavirin in combination in naive patients with chronic hepatitis C: an Italian multicenter experience
Barbaro, G
Di Lorenzo, G
Soldini, M
Giancaspro, G
Pellicelli, A
Grisorio, B
Barbarini, G
JOURNAL OF HEPATOLOGY, 2000, 33 (03) : 448 - 455
[40] Efficacy and Tolerability of Pegylated Interferon-α2a plus Ribavirin versus Pegylated Interferon-α2b plus Ribavirin in Treatment-Naive Chronic Hepatitis C Patients
Lee, Seok
Kim, In Hee
Kim, Seong Hun
Kim, Sang Wook
Lee, Seung Ok
Lee, Soo Teik
Kim, Dae Ghon
Lee, Chang Seop
Choi, Chang Soo
Cho, Eun Young
Kim, Haak Cheoul
INTERVIROLOGY, 2010, 53 (03) : 146 - 153

← 1 2 3 4 5 →